BioCryst Pharmaceuticals, Inc. (BCRX)

NASDAQ: BCRX · Real-Time Price · USD

9.55

-0.39 (-3.92%)

At close: Jun 29, 2026, 4:00 PM EDT

9.52

-0.03 (-0.31%)

Pre-market: Jun 30, 2026, 7:00 AM EDT

BioCryst Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	322.75	874.84	450.71	331.41	270.83	157.17
Revenue Growth (YoY)	42.55%	94.10%	36.00%	22.37%	72.31%	782.38%
Cost of Revenue	19.88	19.08	12.27	4.48	6.41	7.23
Gross Profit	302.86	855.76	438.44	326.93	264.42	149.94
Selling, General & Admin	360.73	348.65	266.35	214.07	159.37	118.82
Research & Development	189.18	166.13	174.64	216.57	253.3	208.81
Other Operating Expenses	697.76	-	-	-	0.19	0.04
Total Operating Expenses	1,248	514.77	440.99	430.64	412.85	327.66
Operating Income	-944.8	340.99	-2.54	-103.71	-148.44	-177.72
Interest Income	9.9	10.67	14.75	15.78	5.13	0.06
Interest Expense	-75.16	-78.87	-98.52	-108.24	-99.09	-59.29
Other Non-Operating Income (Expense)	-19.17	-5.39	-0.64	-30.06	-1.98	55.14
Total Non-Operating Income (Expense)	-84.43	-73.6	-84.41	-122.52	-95.95	-4.09
Pretax Income	-454.18	267.39	-86.95	-226.23	-244.38	-181.81
Provision for Income Taxes	3.81	3.53	1.93	0.31	2.73	2.25
Net Income	-457.98	263.86	-88.88	-226.54	-247.12	-184.06
Net Income to Common	-457.98	263.86	-88.88	-226.54	-247.12	-184.06
Shares Outstanding (Basic)	218	210	207	192	186	179
Shares Outstanding (Diluted)	225	219	207	192	186	179
Shares Change (YoY)	7.81%	5.75%	7.54%	3.38%	3.79%	7.08%
EPS (Basic)	-1.73	1.26	-0.43	-1.18	-1.33	-1.03
EPS (Diluted)	-1.78	1.21	-0.43	-1.18	-1.33	-1.03
Free Cash Flow	310.37	344.9	-53.14	-97.31	-163.1	-144.54
Free Cash Flow Growth	-10.01%	-	-	-	-	-
Free Cash Flow Per Share	1.38	1.58	-0.26	-0.51	-0.88	-0.81
Gross Margin	93.84%	97.82%	97.28%	98.65%	97.63%	95.40%
Operating Margin	-292.74%	38.98%	-0.56%	-31.29%	-54.81%	-113.07%
Profit Margin	-141.90%	30.16%	-19.72%	-68.36%	-91.25%	-117.11%
FCF Margin	96.16%	39.42%	-11.79%	-29.36%	-60.22%	-91.97%
EBITDA	-942.69	342.38	-1.3	-102.05	-147	-176.94
EBITDA Margin	-292.08%	39.14%	-0.29%	-30.79%	-54.28%	-112.58%
EBIT	-944.8	340.99	-2.54	-103.71	-148.44	-177.72
EBIT Margin	-292.74%	38.98%	-0.56%	-31.29%	-54.81%	-113.07%
Effective Tax Rate	-0.84%	1.32%	-2.22%	-0.14%	-1.12%	-1.24%

SEC Filings: 10-K · 10-Q